AIM
USNA icon

Acrospire Investment Management’s Usana Health Sciences USNA Stock Holding History

Acrospire Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,186
Closed -$76K – 1365
2017
Q2 		$76K Sell
1,186
-2,062
-63% -$127K 0.07% 451
2017
Q1 		$187K Sell
3,248
-2,400
-42% -$143K 0.15% 59
2016
Q4 		$346K Buy
+5,648
New +$368K 0.14% 91
2016
Q2 		– Sell
-400
Closed -$24K – 2293
2016
Q1 		$24K Buy
+400
New +$23.5K 0.02% 1453

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's USNA Position: Q3 2017 in Review

Acrospire Investment Management sold out of Usana Health Sciences (USNA) in Q3 2017, closing a stake of 1,186 shares — an estimated $76K sold.

Acrospire Investment Management first reported a position in USNA in Q1 2016 and held it in 4 quarters. The position peaked at $346K in Q4 2016. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

  • Acrospire Investment Management reported no remaining Usana Health Sciences position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,186 Usana Health Sciences shares in Q3 2017, an estimated $76K.
  • Acrospire Investment Management first reported a position in Usana Health Sciences in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Usana Health Sciences position peaked at $346K in Q4 2016.
  • 144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.